Scorpius Holdings Inc., an integrated contract development and manufacturing organization (CDMO), has announced the successful validation of its microbial facilities—signifying that Scorpius’ microbial cleanrooms are now officially approved to manufacture current Good Manufacturing Practice (cGMP) microbial biologic drugs.   This achievement demonstrates Scorpius’ capability to meet the regulatory and client driven high standards required for contract manufacturing of microbial biologics...